12-57091661-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005967.4(NAB2):c.620C>T(p.Pro207Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAB2 | NM_005967.4 | c.620C>T | p.Pro207Leu | missense_variant | 2/7 | ENST00000300131.8 | NP_005958.1 | |
NAB2 | NM_001330305.2 | c.620C>T | p.Pro207Leu | missense_variant | 2/6 | NP_001317234.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAB2 | ENST00000300131.8 | c.620C>T | p.Pro207Leu | missense_variant | 2/7 | 1 | NM_005967.4 | ENSP00000300131.3 | ||
NAB2 | ENST00000342556.6 | c.620C>T | p.Pro207Leu | missense_variant | 2/6 | 5 | ENSP00000341491.6 | |||
NAB2 | ENST00000554718.1 | n.636C>T | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000824 AC: 2AN: 242602Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132410
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1457812Hom.: 0 Cov.: 31 AF XY: 0.00000828 AC XY: 6AN XY: 724848
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.620C>T (p.P207L) alteration is located in exon 2 (coding exon 2) of the NAB2 gene. This alteration results from a C to T substitution at nucleotide position 620, causing the proline (P) at amino acid position 207 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at